Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

354 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Not Yet Recruiting

Individualized Radiation Dose Prescription in HNSCC Based on F-MISO-PET Hypoxia-Imaging

NCT03865277

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Medical Faculty, Albert-Ludwigs-Universität Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Department of Radiation Oncology Heidelberg University Medical School Heidelberg, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim, Klinik für Strahlentherapie und Radioonkologie Mannheim, Baden-Wurttemberg, Germany
  • Uniklinikum Wuerzburg Würzburg, Bavaria, Germany
View Trial Details
Completed

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
Locations
  • State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" Istra, Moscow Oblast, Russia
  • "New Clinic" LLC Pyatigorsk, Stavropol Territory, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, The Altai Republic, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, The Chuvash Republic, Russia
View all 23 locations
View Trial Details
Completed

A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435324

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • State Budgetary Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Oncological Dispensary" Arkhangelsk, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
  • Regional Budgetary Healthcare Institution "Ivanovo Regional Oncological Dispensary" Ivanovo, Russia
View all 34 locations
View Trial Details
Completed

A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma

NCT07435311

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, Russia
  • State Budgetary Healthcare Institution "Regional Oncological Dispensary" Irkutsk, Russia
  • State Budgetary Healthcare Institution of Moscow "Moscow City Oncological Hospital No. 62, Department of Health of Moscow" Istra, Russia
View all 18 locations
View Trial Details
Completed

PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

NCT06366451

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • UC Davis Sacramento, California, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Oregon Health & Science University (OHSU) Portland, Oregon, United States
View Trial Details

Related conditions